These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7554473)

  • 1. PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years.
    Hershfield MS
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S228-32. PubMed ID: 7554473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency.
    Hershfield MS
    Hum Mutat; 1995; 5(2):107-12. PubMed ID: 7749407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of adenosine deaminase deficiency with adenosine deaminase combined with polyethylene glycol].
    Girault D; Le Deist F; Debré M; Pérignon JL; Herbelin C; Griscelli C; Sciudery D; Hershfield M; Fischer A
    Arch Fr Pediatr; 1992 Apr; 49(4):339-43. PubMed ID: 1497422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polyethylene glycol-adenosine deaminase: a new adenosine deaminase deficiency therapy. Value of deoxyadenosine triphosphate determination for therapeutic monitoring].
    Bory C; Boulieu R; Souillet G; Hershfield MS
    Therapie; 1991; 46(4):323-6. PubMed ID: 1948809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement therapy with polyethylene glycol-adenosine deaminase in adenosine deaminase deficiency: overview and case reports of three patients, including two now receiving gene therapy.
    Hershfield MS; Chaffee S; Sorensen RU
    Pediatr Res; 1993 Jan; 33(1 Suppl):S42-7; discussion S47-8. PubMed ID: 8433874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID).
    Chan B; Wara D; Bastian J; Hershfield MS; Bohnsack J; Azen CG; Parkman R; Weinberg K; Kohn DB
    Clin Immunol; 2005 Nov; 117(2):133-43. PubMed ID: 16112907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency.
    Chaffee S; Mary A; Stiehm ER; Girault D; Fischer A; Hershfield MS
    J Clin Invest; 1992 May; 89(5):1643-51. PubMed ID: 1569204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA).
    Hershfield MS
    Immunodeficiency; 1993; 4(1-4):93-7. PubMed ID: 8167743
    [No Abstract]   [Full Text] [Related]  

  • 9. Management options: SCIDS with adenosine deaminase deficiency.
    Hilman BC; Sorensen RU
    Ann Allergy; 1994 May; 72(5):395-403; quiz 403-4, 407. PubMed ID: 8179225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
    Weinberg K; Hershfield MS; Bastian J; Kohn D; Sender L; Parkman R; Lenarsky C
    J Clin Invest; 1993 Aug; 92(2):596-602. PubMed ID: 8349799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase.
    Hershfield MS; Buckley RH; Greenberg ML; Melton AL; Schiff R; Hatem C; Kurtzberg J; Markert ML; Kobayashi RH; Kobayashi AL
    N Engl J Med; 1987 Mar; 316(10):589-96. PubMed ID: 3807953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy.
    Hershfield MS
    Semin Hematol; 1998 Oct; 35(4):291-8. PubMed ID: 9801258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 24-Year Enzyme Replacement Therapy in an Adenosine-deaminase-Deficient Patient.
    Tartibi HM; Hershfield MS; Bahna SL
    Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26684479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase.
    Kaufman DA; Hershfield MS; Bocchini JA; Moissidis IJ; Jeroudi M; Bahna SL
    Pediatrics; 2005 Dec; 116(6):e876-9. PubMed ID: 16263974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase deficiency.
    Hirschhorn R
    Immunodefic Rev; 1990; 2(3):175-98. PubMed ID: 2078332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of an antibody to adenosine-deaminase (ADA) in an ADA-deficient patient receiving polyethylene glycol modified adenosine deaminase.
    Chun JD; Lee N; Kobayashi RH; Chaffee S; Hershfield MS; Stiehm ER
    Ann Allergy; 1993 Jun; 70(6):462-6. PubMed ID: 8507039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase.
    Levy Y; Hershfield MS; Fernandez-Mejia C; Polmar SH; Scudiery D; Berger M; Sorensen RU
    J Pediatr; 1988 Aug; 113(2):312-7. PubMed ID: 3260944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burkitt's lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase.
    Husain M; Grunebaum E; Naqvi A; Atkinson A; Ngan BY; Aiuti A; Roifman CM
    J Pediatr; 2007 Jul; 151(1):93-5. PubMed ID: 17586199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency.
    Ochs HD; Buckley RH; Kobayashi RH; Kobayashi AL; Sorensen RU; Douglas SD; Hamilton BL; Hershfield MS
    Blood; 1992 Sep; 80(5):1163-71. PubMed ID: 1387561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
    Cowan MJ; Shannon KM; Wara DW; Ammann AJ
    Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.